02552 華領醫藥－Ｂ
按盤價 
1.600 -0.070 (-4.192%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 資產回報率 (%) | -14.840% | -20.099% | -30.992% | -32.052% | -30.987% |
| 股東資金回報率 (%) | -110.962% | -55.762% | -55.077% | -43.849% | -34.517% |
| 資本運用回報率 (%) | -14.337% | -21.810% | -40.887% | -36.002% | -37.115% |
邊際利潤分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 48.785% | 43.690% | N/A | N/A | N/A |
| 未計利息、稅項、折舊及攤銷前利潤率 (%) | -239.657% | -979.050% | N/A | N/A | N/A |
| 稅前邊際利潤率 (%) | -275.726% | -1156.355% | N/A | N/A | N/A |
| 純利率 (%) | -275.726% | -1156.355% | N/A | N/A | N/A |
變現能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流動比率 (X) | 6.239 X | 4.991 X | 6.592 X | 9.810 X | 10.300 X |
| 速動比率 (X) | 6.062 X | 4.981 X | 6.592 X | 9.810 X | 10.300 X |
財務槓桿分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 總負債 / 總資產比率 (%) | 94.137% | 75.071% | 50.160% | 38.883% | 15.462% |
| 總債項 / 總資產比率 (%) | 9.723% | 8.701% | 7.916% | 6.735% | 7.172% |
| 淨債項 / 總資產比率 (%) | -74.944% | -35.047% | -66.815% | -79.379% | -80.951% |
| 總債項 / 股東資金比率 (%) | 165.845% | 34.903% | 15.883% | 11.019% | 8.484% |
| 長期債項 / 股東資金比率 (%) | 124.846% | 15.083% | 12.931% | 9.449% | 7.350% |
| 淨債項 / 股東資金比率 (%) | -1278.356% | -140.586% | -134.059% | -129.881% | -95.757% |
| 淨現金 / (債項) ($) | 12.93億 | 3.93億 | 6.04億 | 9.51億 | 10.16億 |
| 每股淨現金 / (債項) ($) | 1.225 | 0.372 | 0.572 | 0.902 | 0.963 |
| 總債項 / 資本運用比率 (%) | 11.386% | 10.458% | 8.978% | 7.392% | 7.853% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
營運效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存貨周轉率日數 (日) | 216.520日 | 70.532日 | N/A | N/A | -- |
| 應收貿易帳周轉率日數 (日) | 28.010日 | 230.647日 | N/A | N/A | N/A |
| 應付貿易帳周轉率日數 (日) | 172.983日 | 464.230日 | N/A | N/A | N/A |
| 備註： | 即時報價更新時間為15/11/2024 17:59 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) () | RMB -142,241,000 |
| 增長率 | 57.877% |
| 每股盈利/(虧損) | RMB -0.150 |
| 每股帳面資產淨值 (¥) | RMB -0.031 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
